NQF Measures | ActiveHealth Management | Life-Saving. Cost-Saving.

04.18.2012
Harvard Medical School Faculty Approve the Clinical Content of ActiveHealth's Maternity Management Program

04.12.2011
ActiveHealth Management Effects North Carolina State Health Plan Member Participation in Care Management Programs

01.19.2012
ActiveHealth CareEngine Monitors and Improves Health Outcomes for Heartland Health Aetna Members


Health Plans \| Employers \| Benefit Consultants \| Physicians \| Members \| Consumers

In 2009, the National Quality Forum (NQF) approved and endorsed 26 quality measures develop by ActiveHealth Management. The measures are intended to help improve healthcare across the U.S. through increased use of electronic data platforms to gather, measure and report on quality information. If you would like to receive information about ActiveHealth’s NQF measures, please submit your information in the form below.
*First Name:
*Last Name:
*Organization:
*Title:
*Address:
*City:
*State:
*Zip Code:
*Phone:
*Email:
For a brief description of each ActiveHealth endorsed measure, click here. Please check the measures that you would like to request: 610: Heart Failure—Use of ACE Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Therapy 611: Hyperlipidemia (Primary Prevention)—Lifestyle Changes and/or Lipid-Lowering Therapy 612: Warfarin—INR Monitoring 613: MI—Use of Beta Blocker Therapy 614: Steroid Use—Osteoporosis Screening 615: Heart Failure—Use of Beta Blocker Therapy 616: Atherosclerotic Disease—Lipid Panel Monitoring 617: High Risk for Pneumococcal Disease—Pneumococcal Vaccination 618: Diabetes with LDL Greater Than 100—Use of a Lipid-Lowering Agent 619: Diabetes with Hypertension or Proteinuria—Use of an ACE Inhibitor or ARB 620: Asthma—Use of Short-Acting Beta Agonist Inhaler for Rescue Therapy 621: Non-Diabetic Nephropathy—Use of ACE Inhibitor or ARB Therapy 622: GERD—Upper Gastrointestinal Study in Adults with Alarm Symptoms 623: Breast Cancer—Cancer Surveillance 624: Atrial Fibrillation—Warfarin Therapy 625: Prostate Cancer—Cancer Surveillance 626: Chronic Kidney Disease—Lipid Profile Monitoring 627: Chronic Kidney Disease with LDL Greater Than or Equal to 130—Use of Lipid Lowering Agent 629: Male Smokers or Family History of Abdominal Aortic Aneurysm (AAA)—Consider Screening for AAA 630: Diabetes and Elevated HbA1C—Use of Diabetes Medications 631: Secondary Prevention of Cardiovascular Events—Use of Aspirin or Antiplatelet Therapy 632: Primary Prevention of Cardiovascular Events in Diabetics (Older Than 40 Years)—Use of Aspirin or Antiplatelet Therapy 633: Osteopenia and Chronic Steroid Use—Treatment to Prevent Osteoporosis 634: Osteoporosis—Use of Pharmacological Treatment 635: Chronic Liver Disease—Hepatitis A Vaccination 636: Atherosclerotic Disease and LDL Greater Than 100—Use of Lipid-Lowering Agent
*Required Fields

If you have any questions, please email contactus@activehealth.net.

Corporate Headquarters
ActiveHealth Management
1333 Broadway
New York, NY 10018
Phone: 212.651.8200

Other Offices and Service
Centers Located in:
Chantilly, VA
Beachwood, OH
Chicago, IL
Rolling Meadows, IL
Greenwood Village, CO

ActiveHealth Management makes available, upon request, information about any financial ownership arrangements between ActiveHealth and other entities engaged in advertising, marketing and provision of goods and services offered through ActiveHealth. Requests for this type of information can be obtained by contacting us at request@activehealth.net.